Development of an innovative gene therapy platform to cure rare hereditary muscle disorders

Project Information

MYOCURE

Grant agreement ID: 667751

DOI 10.3030/667751

Project closed

EC signature date 1 December 2015

Start date 1 January 2016

End date 31 December 2019

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 5 998 937,50

EU contribution € 5 998 937,50

Coordinated by

VRIJE UNIVERSITEIT BRUSSEL
Belgium